| Literature DB >> 35952818 |
Chiranjib Chakraborty1, Manojit Bhattacharya2, Ashish Ranjan Sharma3, Bidyut Mallik4.
Abstract
Omicron, another SARS-CoV-2 variant, has been recorded and reported as a VoC. It has already spread across >30 countries and is a highly mutated variant. We tried to understand the role of mutations in the investigated variants by comparison with previous characterized VoC. We have mapped the mutations in Omicron S-glycoprotein's secondary and tertiary structure landscape using bioinformatics tools and statistical software and developed different models. In addition, we analyzed the effect of diverse mutations in antibody binding regions of the S-glycoprotein on the binding affinity of the investigated antibodies. This study has chosen eight significant mutations in Omicron (D614G, E484A, N501Y, Q493K, K417N, S477N, Y505H G496S), and seven of them are located in the RBD region. We also performed a comparative analysis of the ΔΔG score of these mutations to understand the stabilizing or destabilizing properties of the investigated mutations. The analysis outcome shows that D614G, Q493K, and S477N mutations are stable mutations with ΔΔG scores of 0.351 kcal/mol, 0.470 kcal/mol, and 0.628 kcal/mol, respectively, according to DynaMut estimations. While other mutations (E484A, N501Y, K417N, Y505H, G496S) showed destabilizing results. The D614G, E484A, N501Y, K417N, Y505H, and G496S mutations increased the molecular flexibility of S-glycoprotein to interact with the ACE2 receptor, increasing the variant's infectivity. Our study will contribute to research on the SARS-CoV-2 variant, Omicron, by providing information on the mutational pattern and exciting properties of these eight significant mutations, such as antibody escape and infectivity quotient (stabilizing or destabilizing; increased or decreased molecular flexibility of S-glycoprotein to interact with the human ACE2 receptor).Entities:
Keywords: Omicron; RBD mutation; SARS-CoV-2 VoC; Spike mutation; nAb escape
Mesh:
Substances:
Year: 2022 PMID: 35952818 PMCID: PMC9359758 DOI: 10.1016/j.ijbiomac.2022.07.254
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 8.025
Significant SARS-CoV-2 variants, their lineages, and first documented country.
| Sl No. | Significant SARS-CoV-2 variants | Variants name (WHO label) | SARS-CoV-2 lineages | First documented country |
|---|---|---|---|---|
| 1. | 21K, GR/484A | Omicron | B.1.1.529 | Multiple countries, as November-2021 |
| 2. | 20I/501Y.V1 | Alpha | B.1.1.7 | United Kingdom |
| 3. | 21A, 21I, 21J/20A/S:478K | Delta | B.1.617.2 | India |
| 4. | 20J/501Y.V3 | Gamma | P.1 | Brazil |
| 5. | 20J | Zeta | P.2 | Brazil |
| 6. | 20H/501Y.V2 | Beta | B.1.351 | South Africa |
| 7. | 20C/S:452R | Epsilon | B.1.427/ B.1.429 | USA |
| 8. | 21D, G/484K.V3 | Eta | B.1.525 | USA |
| 9. | 21F, GH/253G.V1 | Iota | B.1.526 | USA |
Fig. 1The flow diagram of our comprehensive study and a schematic diagram shows the location of the mutations selection in our study. (a) A flow diagram of our study to evaluate the mutational landscape of the Omicron (B.1.1.529) variant. (b) A schematic diagram shows the location of the selected eight mutations from the S-glycoprotein for our study. The diagram illustrates that seven mutations were selected from the RBD region, and one mutation was selected from outside the RBD region (D614G).
Fig. 2Mapped mutations in the Omicron variant. (a) The schematic diagram shows mutations in structural proteins (S, E, M, and N) and non-structural proteins (nsp3, nsp4, nsp5, nsp6, nsp12, and nsp14). (b) A statistical model using the number of mutations in structural and non-structural proteins. (c) The schematic diagram shows mutations in the different regions of the S1 and S2 subunits in the S-glycoprotein in Omicron. (d) A statistical model using the number of mutations in the different areas of the S1 and S2 subunit of S-glycoprotein. (e) Comparing mutations in Omicron and other VoC (Delta, Gamma, Alpha), considering structural and non-structural proteins. (f) Comparing mutations in Omicron and other VoC (Delta, Gamma, Alpha), considering S-glycoprotein.
Fig. 3Mapped mutations in the secondary structure landscape of S-glycoprotein in Omicron. (a) Mutations in the N-terminal domain (NTD), considering the secondary structure. (b) Sequence Logo developed using NTD, which shows the sequence conservation in the residue of NTD. (c) Mutations in the receptor-binding domain (RBD), considering the secondary structure. (d) The sequence Logo developed using the RBD shows the sequence conservation in the residue of RBD. (e) Mutations in the receptor heptad repeat (HR1), considering the secondary structure. (f) Sequence Logo developed using heptad repeat (HR1) shows the sequence conservation in the residue of HR1.
Fig. 4Mapped mutations in the tertiary structure landscape of S-glycoprotein in Omicron. (a) Location of mutations in the tertiary structure landscape of S-glycoprotein highlighting RBD. (b) Location of mutations in the RBM in tertiary structure landscape of S-glycoprotein.
Significant mutations within the S-protein of four SARS-CoV-2 variants; Omicron (B.1.1.529), Delta (B.1.617.2), Gamma (P.1), and Alpha (B.1.1.7).
| Variants name | Mutations in Spike (S) glycoprotein | |
|---|---|---|
| Other than RBD region | RBD region | |
| Omicron (B.1.1.529) | A67V, Δ69–70, T95I, G142D, Δ143–145, Δ211, L212I,ins214EPE,T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H |
| Delta (B.1.617.2) | G142D, T19R, R158G, D614G, P681R, D950N, E156del, F157del | L452R, T478K |
| Gamma (P.1) | L18F, T20N, P26S, D138Y, R190S, H655Y, T1027I | K417T, E484K, N501Y |
| Alpha (B.1.1.7) | HV 69–70 deletion, Y144 deletion, A570D, P681H, T716I, S982A, D1118H | N501Y |
Mutation in antibodies interaction area within S-protein of Omicron variant. Here, we mapped the mutations in the residue of interaction with antibodies (nAbs) or the mutations in the adjacent area of interaction with antibodies (nAbs). It also illustrates the SARS-CoV-2 neutralizing antibodies (nAbs), their class, and PDB Id used in this study.
| Sl No | Antibody name | Antibody class | PDB id | Amino acids residue and positions of S-glycoprotein that interact with neutralizing antibodies (nAbs) | Mutations in the residue of interaction with antibodies (nAbs) or the mutations in the residues of adjacent area of interaction with antibodies (nAbs) |
|---|---|---|---|---|---|
| 1 | BD-744 | Class-1 | E340, T345, R346, N354, Y449, N450, L452, R466, I468, T470, F490, L492 | G339D, G446S, Q493K | |
| BD-813 | |||||
| T415, D420, Y421, L455, F456, R457, N460, Y473, A475, S477, T478, F486, N487, Y489, Y505 | K417N, S477N, T478K, E484K, Y505H | ||||
| 2 | BG1-22 | Class-1 | R408, D420, Y421, T415, A457, N460, A475, S477, F486, Q493, Y495, T500, V503, | K417N, S477N, E484A, Q493K, G496S, Q498R, V505H | |
| 3 | P2B-1A10 | Class-1 | K417, Y449, L455, F456, A475, N487, Y489, Q493, G496, T500, N501, G502, Y505 | K417N, G446S, S477N, Q493K, G496S, Q498R, N501Y, Y505H | |
| 4 | 13G9 | Class-2 | Q493, E484, K458, S477, F486 | E484A, Q493K, S477N | |
| 5 | C548 | Class-2 | L455, F486, Q498, F490, Q493, E484 | E484A, Q493K, Q498R | |
| 6 | C051 | Class-2 | L455, Q493, S494 | Q493K, G496S | |
| 7 | C032 | Class-3 | T345, R346, N440, L441, K444, V445, N448, | N440K, G446S | |
| 8 | 47D11 | Class-3 | F338, F342, Y365, V367, L368, F374 | G339D, S373P, S375F | |
| 9 | BG10-19 | Class-3 | V445, Y489, F490, Q498, N343, F374, N450, N440, L441, R346, W436, V367 | G446S, Q493K, G496S, Q498R, S373P, N440K | |
| 10 | C118. | Class-4 | L355, Y365, F364, C366, G391, D392, V394, K417, F416, D415, D414, P399. G400, Q401, T402 | K417N | |
| 11 | S2X259 | Class-4 | Y369, C379, K378, F377, T385, S383, Y380, R408, D405 | S371L, S375F | |
| 12 | 5A6 | Class-4 | D471, N481, E484, Y489, F490, N487, F486 | E484A, Q493K |
Fig. 5Spotted mutations in the antibody (nAb) binding regions of S-glycoprotein in Omicron. (a) BG1–22 antibody (Class-1 antibody) and its interaction with S-glycoprotein show the residues involved in this interaction. (b) 13G9 antibody (Class-2 antibody) and its interaction with S-glycoprotein show the residues involved in this interaction. (c) Predicted mutation position in the nAb binding regions or adjacent mutations in the nAb binding areas.
Fig. 6Illustrated significant properties of D614G. (a) Vibrational entropy energy of D614G with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type D614G mutation.
Fig. S1Illustrated atomic fluctuations and deformation energies of D614G mutation. (a) Residue-wise RMS fluctuation of D614G mutation. (b) Atomic fluctuations in a virtual approach in wild type to mutant type in D614G mutation. (c) Deformation energies in a virtual manner in wild type to mutant type in D614G mutation.
Fig. 7Mapped important properties of E484A. (a) Vibrational entropy energy of E484A with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type E484A mutation.
Fig. S2Mapped atomic fluctuations and deformation energies of E484A. (a) Residue-wise RMS fluctuation of E484A mutation. (b) Atomic fluctuations in a virtual approach in wild type to mutant type in E484A mutation. (c) Deformation energies in a virtual manner in wild type to mutant type in E484A mutation.
Fig. 8Evaluated significant properties of N501Y. (a) Vibrational entropy energy of N501Y with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type N501Y mutation.
Fig. S3Evaluated atomic fluctuations and deformation of N501Y. (a) Residue-wise RMS fluctuation of N501Y mutation. (b) Atomic fluctuations in a virtual approach in wild type to mutant type in N501Y mutation. (c) Deformation Energies in a virtual manner in wild type to mutant type in N501Y mutation.
Fig. 9Mapped noteworthy properties of Q493K. (a) Vibrational entropy energy of Q493K with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type Q493K mutation.
Fig. S4Mapped atomic fluctuations and deformation of Q493K. (a) Residue-wise RMS fluctuation of Q493K mutation. (b) Atomic fluctuations in a virtual approach in wild type to mutant type in Q493K mutation. (c) Deformation energies in a virtual manner in wild type to mutant type in Q493K mutation.
Fig. 10Illustrated significant properties of K417N. (a) Vibrational entropy energy of K417N with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type K417N mutation.
Fig. S5Illustrated atomic fluctuations and deformation of K417N. (a) Residue-wise RMS fluctuation of K417N mutation. (b) Atomic fluctuations in a virtual approach in wild type to mutant type in K417N mutation. (c) Deformation energies in a virtual manner in wild type to mutant type in K417N mutation
Fig. 11Evaluated important properties of S477N. (a) Vibrational entropy energy of S477N with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type S477N mutation.
Fig. S6Evaluated atomic fluctuations and deformation of S477N. (a) Residue-wise RMS fluctuation of S477N mutation. (b) Atomic fluctuations in a virtual approach in wild type to mutant type in S477N mutation. (c) Deformation Energies in a virtual manner in wild type to mutant type in S477N mutation.
Fig. 12Mapped noteworthy properties of Y505H. (a) Vibrational entropy energy of Y505H with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type Y505H mutation.
Fig. S7Mapped atomic fluctuations and deformation of Y505H. (a) Residue-wise RMS fluctuation of Y505H mutation. (b) Atomic fluctuations in a virtual approach in wild-type to mutant-type Y505H mutation. (c) Deformation energies in a virtual manner in wild type to mutant type in Y505H mutation.
Fig. 13Illustrated significant properties of G496S. (a) Vibrational entropy energy of G496S with a visual representation through ΔΔG score prediction. (b) Interatomic interactions of wild type to mutant type G496S mutation.
Fig. S8Illustrated atomic fluctuations and deformation of G496S. (a) Residue-wise RMS fluctuation of G496S mutation. (b) Atomic fluctuations in a virtual approach in wild type to mutant type in G496S mutation. (c) Deformation energies in a virtual manner in wild type to mutant type in G496S mutation.
Major mutations that were chosen for our study and their characteristics reported by different researchers.
| Sl. No. | Significant mutations of Omicron variant | Features of mutations | Reference |
|---|---|---|---|
| 1. | D614G | Enhance the main protein chain flexibility which shown high infectivity rate with better binding affinity of S-protein to the ACE2 receptor. This mutation boost up the viral fitness to amplify replication and transmission property of SARS-CoV-2 virus. | |
| 2. | E484A | Crucial role in the advancement of viral infectivity, transmissibility, and/or antigenicity. This mutation reduces the neutralization potency of antibodies. | |
| 3. | N501Y | Increasing the electrostatic interactions between S-protein and ACE2 by a strong hydrogen bond near the mutation site. Which also affect viral-host cells fusion and increased viral transmission rate. | |
| 4. | Q493K | This mutation considerably contributes to the binding energies of the RBD of S-protein and ACE2 and almost doubled the electrostatic potential S-protein-ACE2 complex. | |
| 5. | K417N | The RBD-ACE2 interactions were expressively increased due to K417N mutation by increasing the RBD-ACE2 free energy of binding. This single mutation also destabilizes the stated interaction complex through a combination of slower binding and faster dissociation. | |
| 6. | S477N | This important mutation results in increased binding affinity of S-protein RBD region for the ACE2 receptor. It also facilitates the immune escape mechanism by increasing receptor-binding affinity freely on antibody recognition of epitopes. | |
| 7. | Y505H | Y505H mutation causing in reduced protein stability and an augmented risk of viral disease | |
| 8. | G496S | It change the shape of the receptor-binding motif (RBM) and generates a steric interference for the binding of Abs to the RBD of S-protein, results in loss of Ab-RBD interactions. |
Comparative analysis of or ΔΔG score of significant mutations of Omicron variant.
| ΔΔG Prediction | NMA based prediction | Other structure-based predictions | Δ Vibrational entropy energy between wild-type and mutant | Remark | ||||
|---|---|---|---|---|---|---|---|---|
| Sl no. | Significant mutations of Omicron variant | ΔΔG (kcal/mol) | ΔΔG ENCoM (kcal/mol) | ΔΔG mCSM (kcal/mol) | ΔΔG SDM (kcal/mol) | ΔΔG DUET (kcal/mol) | ΔΔSVib ENCoM (kcal.mol−1.K−1) | |
| 1 | D614G | 0.351, Stabilizing | −0.134, Destabilizing | −0.514, Destabilizing | 2.510, Stabilizing | 0.171, Stabilizing | 0.168 | Increase of molecular flexibility |
| 2 | E484A | −0.456, Destabilizing | −0.377, Destabilizing | −0.415, Destabilizing | 0.320, Stabilizing | −0.128, Destabilizing | 0.471 | Increase of molecular flexibility |
| 3 | N501Y | −0.203, Destabilizing | −0.094, Destabilizing | −0.457, Destabilizing | 0.280, Stabilizing | −0.471, Destabilizing | 0.117 | Increase of molecular flexibility |
| 4 | Q493K | 0.470, Stabilizing | 0.066, Destabilizing | 0.194, Stabilizing | 0.580, Stabilizing | 0.794, Stabilizing | −0.082 | Decrease of molecular flexibility |
| 5 | K417N | −0.932, Destabilizing | −0.677, Destabilizing | −1.138, Destabilizing | −0.280, Destabilizing | −1.123, Destabilizing | 0.846 | Increase of molecular flexibility |
| 6 | S477N | 0.628, Stabilizing | 0.064, Destabilizing | −0.215, Destabilizing | 0.780, Stabilizing | 0.235, Stabilizing | −0.080 | Decrease of molecular flexibility |
| 7 | Y505H | −0.510, Destabilizing | −0.305, Destabilizing | −0.119, Destabilizing | 0.380, Stabilizing | 0.143, Stabilizing | 0.381 | Increase of molecular flexibility |
| 8 | G496S | −0.097, Destabilizing | −0.014, Destabilizing | −0.763, Destabilizing | −1.010, Destabilizing | −0.614, Destabilizing | 0.018 | Increase of molecular flexibility |
Fig. 14Schematic representation shows Omicron S-glycoprotein significant mutations, and their effects on stability and flexibility changes due to amino acid substitution (a) Schematic representation shows significant mutations of Omicron S-glycoprotein and their effects on stability. (b) Schematic representation shows significant mutations of Omicron S-glycoprotein and their effects on flexibility.